[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 2,835
Citations 0
Lab Reports
September 6, 2016

Liquid Biopsy to Evaluate Efficacy of Cancer Therapy

JAMA. 2016;316(9):917. doi:10.1001/jama.2016.12068

Using patient-derived circulating tumor cell (CTC) cultures obtained from blood-drawn liquid biopsies, a team led by investigators at the Singapore–Massachusetts Institute of Technology Alliance for Research and Technology Centre has developed a new approach to assess the effectiveness of cancer treatment within 2 weeks (Khoo BL et al. Sci Adv. 2016;2[7]:e1600274).

The technique uses a microfluidic assay integrated with 2 components: custom-designed tapered microwells for cutting and a gradient generator to carry out drug screening. Cultures are maintained as multilayered clusters to better reflect the in vivo state of a tumor.

First Page Preview View Large
First page PDF preview
First page PDF preview